APO RESEARCH · REPORT
Diagnostic Reagent
Diagnostic Reagent is any reagent that is used in vitro or in vivo for detection or screening of a particular disease or any health-related issue.
Product & engineering
Understand the product.
Diagnostic Reagent is any reagent that is used in vitro or in vivo for detection or screening of a particular disease or any health-related issue.
Selected research
Industry Research
Diagnostic Reagent Industry Research Report 2026
Market perspective
Diagnostic Reagent is any reagent that is used in vitro or in vivo for detection or screening of a particular disease or any health-related issue.
Global Diagnostic Reagent key players include Roche, Siemens, Abbott, Danaher, Thermo Fisher, etc. Global top five manufacturers hold a share about 50%.
North America is the largest market, with a share about 45%, followed by West Europe and Japan, both have a share about 40 percent.
Read the full market overview
In terms of product, Immune diagnosis is the largest segment, with a share over 30%. And in terms of application, the largest application is Detection of Infectious Diseases, followed by Endocrine Examination and Immunoassay Method.
Report Scope
This report quantifies the global Diagnostic Reagent market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Diagnostic Reagent.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diagnostic Reagent Market by Company
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
JNJ
Sysmex
KHB
DaAn Gene
Leadman
BioSino
BSBE
Maccura
Diagnostic Reagent Segment by Type
In Vivo Diagnostic Reagents
In Vitro Diagnostic Reagents
Diagnostic Reagent Segment by Application
Endocrine Examination
Tumor Detection
Detection of Infectious Diseases
Immunoassay Method
Cytokine Examination
Myocardial Infarction Detection
PCR
Eugenics Detection (TORCH)
Other
Diagnostic Reagent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Reagent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Diagnostic Reagent companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- In Vivo Diagnostic Reagents
- In Vitro Diagnostic Reagents
Applications
- Endocrine Examination
- Tumor Detection
- Detection of Infectious Diseases
- Immunoassay Method
- Cytokine Examination
- Myocardial Infarction Detection
- PCR
- Eugenics Detection (TORCH)
- Other
Companies covered
- Roche
- Siemens
- Abbott
- Danaher
- Thermo Fisher
- BioMerieux
- Bio-Rad
- BD
- JNJ
- Sysmex
- KHB
- DaAn Gene
- Leadman
- BioSino
- BSBE
- Maccura
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Diagnostic Reagent by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 In Vivo Diagnostic Reagents
- 2.2.3 In Vitro Diagnostic Reagents
- 2.3 Diagnostic Reagent by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Endocrine Examination
- 2.3.3 Tumor Detection
- 2.3.4 Detection of Infectious Diseases
- 2.3.5 Immunoassay Method
- 2.3.6 Cytokine Examination
- 2.3.7 Myocardial Infarction Detection
- 2.3.8 PCR
- 2.3.9 Eugenics Detection (TORCH)
- 2.3.10 Other
- 2.4 Assumptions and Limitations
3 Diagnostic Reagent Breakdown Data by Type
- 3.1 Global Diagnostic Reagent Historic Market Size by Type (2021-2026)
- 3.2 Global Diagnostic Reagent Forecasted Market Size by Type (2027-2032)
4 Diagnostic Reagent Breakdown Data by Application
- 4.1 Global Diagnostic Reagent Historic Market Size by Application (2021-2026)
- 4.2 Global Diagnostic Reagent Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Diagnostic Reagent Market Perspective (2021-2032)
- 5.2 Global Diagnostic Reagent Growth Trends by Region
- 5.2.1 Global Diagnostic Reagent Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Diagnostic Reagent Historic Market Size by Region (2021-2026)
- 5.2.3 Diagnostic Reagent Forecasted Market Size by Region (2027-2032)
- 5.3 Diagnostic Reagent Market Dynamics
- 5.3.1 Diagnostic Reagent Industry Trends
- 5.3.2 Diagnostic Reagent Market Drivers
- 5.3.3 Diagnostic Reagent Market Challenges
- 5.3.4 Diagnostic Reagent Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Diagnostic Reagent Players by Revenue
- 6.1.1 Global Top Diagnostic Reagent Players by Revenue (2021-2026)
- 6.1.2 Global Diagnostic Reagent Revenue Market Share by Players (2021-2026)
- 6.2 Global Diagnostic Reagent Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Diagnostic Reagent Head Office and Area Served
- 6.4 Global Diagnostic Reagent Players, Product Type & Application
- 6.5 Global Diagnostic Reagent Manufacturers Established Date
- 6.6 Global Diagnostic Reagent Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Diagnostic Reagent Market Size (2021-2032)
- 7.2 North America Diagnostic Reagent Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Diagnostic Reagent Market Size by Country (2021-2026)
- 7.4 North America Diagnostic Reagent Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Diagnostic Reagent Market Size (2021-2032)
- 8.2 Europe Diagnostic Reagent Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Diagnostic Reagent Market Size by Country (2021-2026)
- 8.4 Europe Diagnostic Reagent Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Diagnostic Reagent Market Size (2021-2032)
- 9.2 Asia-Pacific Diagnostic Reagent Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Diagnostic Reagent Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Diagnostic Reagent Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Diagnostic Reagent Market Size (2021-2032)
- 10.2 South America Diagnostic Reagent Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Diagnostic Reagent Market Size by Country (2021-2026)
- 10.4 South America Diagnostic Reagent Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Diagnostic Reagent Market Size (2021-2032)
- 11.2 Middle East & Africa Diagnostic Reagent Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Diagnostic Reagent Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Diagnostic Reagent Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche
- 12.1.1 Roche Company Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Revenue in Diagnostic Reagent Business (2021-2026)
- 12.1.4 Roche Diagnostic Reagent Product Portfolio
- 12.1.5 Roche Recent Developments
- 12.2 Siemens
- 12.2.1 Siemens Company Information
- 12.2.2 Siemens Business Overview
- 12.2.3 Siemens Revenue in Diagnostic Reagent Business (2021-2026)
- 12.2.4 Siemens Diagnostic Reagent Product Portfolio
- 12.2.5 Siemens Recent Developments
- 12.3 Abbott
- 12.3.1 Abbott Company Information
- 12.3.2 Abbott Business Overview
- 12.3.3 Abbott Revenue in Diagnostic Reagent Business (2021-2026)
- 12.3.4 Abbott Diagnostic Reagent Product Portfolio
- 12.3.5 Abbott Recent Developments
- 12.4 Danaher
- 12.4.1 Danaher Company Information
- 12.4.2 Danaher Business Overview
- 12.4.3 Danaher Revenue in Diagnostic Reagent Business (2021-2026)
- 12.4.4 Danaher Diagnostic Reagent Product Portfolio
- 12.4.5 Danaher Recent Developments
- 12.5 Thermo Fisher
- 12.5.1 Thermo Fisher Company Information
- 12.5.2 Thermo Fisher Business Overview
- 12.5.3 Thermo Fisher Revenue in Diagnostic Reagent Business (2021-2026)
- 12.5.4 Thermo Fisher Diagnostic Reagent Product Portfolio
- 12.5.5 Thermo Fisher Recent Developments
- 12.6 BioMerieux
- 12.6.1 BioMerieux Company Information
- 12.6.2 BioMerieux Business Overview
- 12.6.3 BioMerieux Revenue in Diagnostic Reagent Business (2021-2026)
- 12.6.4 BioMerieux Diagnostic Reagent Product Portfolio
- 12.6.5 BioMerieux Recent Developments
- 12.7 Bio-Rad
- 12.7.1 Bio-Rad Company Information
- 12.7.2 Bio-Rad Business Overview
- 12.7.3 Bio-Rad Revenue in Diagnostic Reagent Business (2021-2026)
- 12.7.4 Bio-Rad Diagnostic Reagent Product Portfolio
- 12.7.5 Bio-Rad Recent Developments
- 12.8 BD
- 12.8.1 BD Company Information
- 12.8.2 BD Business Overview
- 12.8.3 BD Revenue in Diagnostic Reagent Business (2021-2026)
- 12.8.4 BD Diagnostic Reagent Product Portfolio
- 12.8.5 BD Recent Developments
- 12.9 JNJ
- 12.9.1 JNJ Company Information
- 12.9.2 JNJ Business Overview
- 12.9.3 JNJ Revenue in Diagnostic Reagent Business (2021-2026)
- 12.9.4 JNJ Diagnostic Reagent Product Portfolio
- 12.9.5 JNJ Recent Developments
- 12.10 Sysmex
- 12.10.1 Sysmex Company Information
- 12.10.2 Sysmex Business Overview
- 12.10.3 Sysmex Revenue in Diagnostic Reagent Business (2021-2026)
- 12.10.4 Sysmex Diagnostic Reagent Product Portfolio
- 12.10.5 Sysmex Recent Developments
- 12.11 KHB
- 12.11.1 KHB Company Information
- 12.11.2 KHB Business Overview
- 12.11.3 KHB Revenue in Diagnostic Reagent Business (2021-2026)
- 12.11.4 KHB Diagnostic Reagent Product Portfolio
- 12.11.5 KHB Recent Developments
- 12.12 DaAn Gene
- 12.12.1 DaAn Gene Company Information
- 12.12.2 DaAn Gene Business Overview
- 12.12.3 DaAn Gene Revenue in Diagnostic Reagent Business (2021-2026)
- 12.12.4 DaAn Gene Diagnostic Reagent Product Portfolio
- 12.12.5 DaAn Gene Recent Developments
- 12.13 Leadman
- 12.13.1 Leadman Company Information
- 12.13.2 Leadman Business Overview
- 12.13.3 Leadman Revenue in Diagnostic Reagent Business (2021-2026)
- 12.13.4 Leadman Diagnostic Reagent Product Portfolio
- 12.13.5 Leadman Recent Developments
- 12.14 BioSino
- 12.14.1 BioSino Company Information
- 12.14.2 BioSino Business Overview
- 12.14.3 BioSino Revenue in Diagnostic Reagent Business (2021-2026)
- 12.14.4 BioSino Diagnostic Reagent Product Portfolio
- 12.14.5 BioSino Recent Developments
- 12.15 BSBE
- 12.15.1 BSBE Company Information
- 12.15.2 BSBE Business Overview
- 12.15.3 BSBE Revenue in Diagnostic Reagent Business (2021-2026)
- 12.15.4 BSBE Diagnostic Reagent Product Portfolio
- 12.15.5 BSBE Recent Developments
- 12.16 Maccura
- 12.16.1 Maccura Company Information
- 12.16.2 Maccura Business Overview
- 12.16.3 Maccura Revenue in Diagnostic Reagent Business (2021-2026)
- 12.16.4 Maccura Diagnostic Reagent Product Portfolio
- 12.16.5 Maccura Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst